Thank you for participating as a China Conference: Southeast Asia (CCSEA) delegate, scheduled for February 18-19, 2020 in Manila, Philippines. We would like to share updates about our event with you.

We have been carefully monitoring the spread of the Coronavirus, the recommendations by the World Health Organization, as well as health and international travel advisories. In the interest of your safety, we are postponing the event. We will be in touch shortly with a new conference date.

We appreciate your patience and sincerely apologise for any inconvenience this may have caused. We look forward to having you join our conference later this year.

Thank you very much.


Dr. Dario Heymann

Chief Research Officer, Galen Growth

About me

Dario is Chief Research Officer and founding member of Galen Growth. He started the building of HealthTech Alpha; the world’s only database and venture analytics platform dedicated to Digital Health and leads its continuous development. HealthTech Alpha, remains the only true analytics platform for digital health, delivering accurate and regularly curated information to investors, industry innovation leaders and startup CxOs.

As well as managing the development of the analytics platform, Dario also leads the research, market intelligence and client missions of the Digital Health ecosystem which helps inform and improve organisations’ overall digital health strategy by grounding decisions. Dario helps organisations grow by providing insights and comprehensive sources, vital to monitor the pulse of the ecosystem and accelerate business strategies.

Prior to Galen Growth, Dario has worked in drug discovery mainly focused on the development of novel drugs in oncology, both in big pharma and academia in Singapore, China and Germany. Dario holds a doctorate in Material Science and Engineering and Masters in Material Science & Engineering, Biochemistry, and Molecular Biology.